Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: Results from a randomized study

Những quyển sách tương tự

• Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study
  Bằng: Romanowski, Barbara, et al.
  Được phát hành: (2015)
• Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: Results from a randomized study
  Bằng: Romanowski, Barbara, et al.
  Được phát hành: (2014)
• Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine
  Bằng: Folschweiller, Nicolas, et al.
  Được phát hành: (2019)
• Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15–55 years
  Bằng: Schwarz, Tino F, et al.
  Được phát hành: (2011)
• Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial
  Bằng: Huang, Li-Min, et al.
  Được phát hành: (2017)